SCHEMBL30659929

SCHEMBL30659929

Cc1oc2ccc(OCc3ccccc3)cc2c1COS(C)(=O)=O

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CASP3 P42574 2/20 0.60
SENP8 Q96LD8 2/20 0.60
SENP7 Q9BQF6 2/20 0.60
SENP6 Q9GZR1 2/20 0.60
L3MBTL1 Q9Y468 2/20 0.57
PKM P14618 1/20 0.57
SLC26A4 O43511 6/20 0.49
KMT2A Q03164 5/20 0.49
MEN1 O00255 4/20 0.49
MAOB P27338 5/20 0.49
BLM P54132 1/20 0.49
ATM Q13315 1/20 0.49
LMNA P02545 1/20 0.49
HTT P42858 1/20 0.49
ACHE P22303 1/20 0.49
MAOA P21397 3/20 0.48
NPC1 O15118 1/20 0.48
RAB9A P51151 1/20 0.48
TDP1 Q9NUW8 1/20 0.48
PTGER4 P35408 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26693504 1.00 CASP3 (0.60) CASP3SENP8SENP7SENP6L3MBTL1
SCHEMBL5746156 0.82 CASP3 (0.63) CASP3SENP8SENP7SENP6L3MBTL1
SCHEMBL6976339 0.82 CASP3 (0.62) CASP3SENP8SENP7SENP6L3MBTL1
SCHEMBL26693543 0.82 CASP3 (0.66) CASP3SENP8SENP7SENP6L3MBTL1
SCHEMBL26693510 0.79 CASP3 (0.59) CASP3SENP8SENP7SENP6L3MBTL1
SCHEMBL26693529 0.76 CASP3 (0.65) CASP3SENP8SENP7SENP6L3MBTL1
SCHEMBL3173845 0.76 S1PR1 (0.52) CASP3SENP8SENP7SENP6L3MBTL1
SCHEMBL24470655 0.76 CASP3 (0.84) CASP3SENP8SENP7SENP6L3MBTL1
SCHEMBL29713158 0.76 CASP3 (0.84) CASP3SENP8SENP7SENP6L3MBTL1
SCHEMBL24470548 0.76 CASP3 (0.71) CASP3SENP8SENP7SENP6L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4532012-A1 NEW DERIVATIVES FOR TREATING TRPM3 MEDIATED DISORDERS Katholieke Universiteit Leuven KU Leuven Research & Development (BE) 2025-04-09 EP disclosed
WO-2023227696-A1 NEW DERIVATIVES FOR TREATING TRPM3 MEDIATED DISORDERS KATHOLIEKE UNIVERSITEIT LEUVEN (BE) 2023-11-30 WO disclosed